News

Sanofi-Aventis launched a hostile takeover bid for Cambridge, Massachusetts-based Genzyme last October, only to meet stiff resistance from Genzyme's founder and CEO Henri Termeer.
Sanofi-Aventis launched a hostile takeover bid for Cambridge, Massachusetts-based Genzyme last October, only to meet stiff resistance from Genzyme's founder and CEO Henri Termeer.
Sanofi-Aventis shares rose on the announcement, and in mid-afternoon trading Paris time were up 3.5 percent at euro51.56. In U.S. premarket trading, Genzyme stock rose $1.22 to $75.52.
In trading Monday afternoon, shares of Genzyme rose $2.05, or 2.9 percent, to $73.15, while U.S.-traded shares of Sanofi added 88 cents to $34.23. Typically, due diligence can take weeks or months.
Eleven years after buying Genzyme, Sanofi officially ditches its ... W hen the French pharmaceutical giant Sanofi starts moving 2,500 employees from 10 sites in Massachusetts into a pair of new ...
Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, ... Sanofi Genzyme priced Dupixent at $37,000 per patient, ...
France's Sanofi-Aventis on Monday launched an $18.5 billion hostile takeover offer for Genzyme Corp., stepping up its effort to capture the U.S. biotech company's promising drugs for high choles ...
With some 5,000 workers in Massachusetts, Sanofi Genzyme continues to be the state’s largest employer in the life sciences industry. Genzyme received a $14.3 million grant from the Massachusetts ...
Michael Fein/BloombergPeople enter Genzyme's headquarters in Cambridge, Mass., late last month. Genzyme, the world's largest maker of drugs for rare genetic diseases, has rebuffed Sanofi-Aventis ...
It's the second-largest buyout in bio-tech history. French drug-maker Sanofi Aventis has agreed to buy the Cambridge-based firm Genzyme for more than $20 billion, or at least $74 a share.
To be fair, many people long ago stopped using the Genzyme name in Massachusetts (although it’s visible in the lobby of Sanofi’s building at 50 Binney St. in Cambridge).
Sanofi Genzyme's new president, ... Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold.